Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 1
1973 1
1974 2
1976 1
1977 1
1978 1
1980 1
1981 5
1982 1
1983 2
1984 5
1985 3
1986 3
1987 2
1989 2
1990 4
1991 3
1992 4
1993 2
1994 1
1995 1
1997 1
1998 1
2000 3
2002 2
2004 4
2005 4
2006 1
2007 4
2008 7
2009 1
2011 3
2012 6
2013 10
2014 4
2015 5
2016 4
2017 15
2018 11
2019 12
2020 25
2021 23
2022 20
2023 13
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Effects of enteral nutrition and parenteral nutrition on survival in patients with advanced cancer cachexia: Analysis of a multicenter prospective cohort study.
Amano K, Maeda I, Ishiki H, Miura T, Hatano Y, Tsukuura H, Taniyama T, Matsumoto Y, Matsuda Y, Kohara H, Morita T, Mori M; East-Asian collaborative cross-cultural Study to Elucidate the Dying process (EASED) Investigators. Amano K, et al. Clin Nutr. 2021 Mar;40(3):1168-1175. doi: 10.1016/j.clnu.2020.07.027. Epub 2020 Jul 31. Clin Nutr. 2021. PMID: 32771283
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. Ueki K, et al. Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3. Epub 2017 Oct 24. Lancet Diabetes Endocrinol. 2017. PMID: 29079252 Clinical Trial.
SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression.
Hashimoto R, Takahashi J, Shirakura K, Funatsu R, Kosugi K, Deguchi S, Yamamoto M, Tsunoda Y, Morita M, Muraoka K, Tanaka M, Kanbara T, Tanaka S, Tamiya S, Tokunoh N, Kawai A, Ikawa M, Ono C, Tachibana K, Kondoh M, Obana M, Matsuura Y, Ohsumi A, Noda T, Yamamoto T, Yoshioka Y, Torisawa YS, Date H, Fujio Y, Nagao M, Takayama K, Okada Y. Hashimoto R, et al. Among authors: kosugi k. Sci Adv. 2022 Sep 23;8(38):eabo6783. doi: 10.1126/sciadv.abo6783. Epub 2022 Sep 21. Sci Adv. 2022. PMID: 36129989 Free PMC article.
Manipulating the Alpha Level Cannot Cure Significance Testing.
Trafimow D, Amrhein V, Areshenkoff CN, Barrera-Causil CJ, Beh EJ, Bilgiç YK, Bono R, Bradley MT, Briggs WM, Cepeda-Freyre HA, Chaigneau SE, Ciocca DR, Correa JC, Cousineau D, de Boer MR, Dhar SS, Dolgov I, Gómez-Benito J, Grendar M, Grice JW, Guerrero-Gimenez ME, Gutiérrez A, Huedo-Medina TB, Jaffe K, Janyan A, Karimnezhad A, Korner-Nievergelt F, Kosugi K, Lachmair M, Ledesma RD, Limongi R, Liuzza MT, Lombardo R, Marks MJ, Meinlschmidt G, Nalborczyk L, Nguyen HT, Ospina R, Perezgonzalez JD, Pfister R, Rahona JJ, Rodríguez-Medina DA, Romão X, Ruiz-Fernández S, Suarez I, Tegethoff M, Tejo M, van de Schoot R, Vankov II, Velasco-Forero S, Wang T, Yamada Y, Zoppino FCM, Marmolejo-Ramos F. Trafimow D, et al. Among authors: kosugi k. Front Psychol. 2018 May 15;9:699. doi: 10.3389/fpsyg.2018.00699. eCollection 2018. Front Psychol. 2018. PMID: 29867666 Free PMC article. Review.
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Kurozumi A, Hatazaki M, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ryomoto K, Kato K, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I; UTOPIA study investigators. Katakami N, et al. Among authors: kosugi k. Cardiovasc Diabetol. 2023 Jun 22;22(1):143. doi: 10.1186/s12933-023-01879-4. Cardiovasc Diabetol. 2023. PMID: 37349722 Free PMC article. Clinical Trial.
Treatment Approaches for Malignant Pleural Effusion.
Yagi Y, Kosugi K, Tanimoto T. Yagi Y, et al. Among authors: kosugi k. JAMA. 2018 Apr 10;319(14):1506-1507. doi: 10.1001/jama.2018.1319. JAMA. 2018. PMID: 29634824 No abstract available.
Targeted-release budesonide therapy for IgA nephropathy.
Tsuda K, Tanimoto T, Mori J, Kosugi K, Komatsu T. Tsuda K, et al. Among authors: kosugi k. Lancet. 2017 Dec 16;390(10113):2625. doi: 10.1016/S0140-6736(17)32145-1. Lancet. 2017. PMID: 29256403 No abstract available.
The Long-Term Natural History of Fibrous Dysplasia.
Ishida K, Sakamoto Y, Kosugi K, Miwa T, Toda M. Ishida K, et al. Among authors: kosugi k. J Craniofac Surg. 2024 May 6. doi: 10.1097/SCS.0000000000010245. Online ahead of print. J Craniofac Surg. 2024. PMID: 38709064
212 results